poisar

Stocks · News reference

This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

BenzingaAvi Kapoor

Analysts initiate coverage: Buy on IonQ ($60), Jack Henry ($193) and 10X Genomics ($110); Overweight Lexicon ($8); In-Line Fortive ($60).

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Fortive Corp (FTV)

    Filed: 2026-09-10 AccNo: 0001104659-26-106735 Size: 239 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

  2. The Motley FoolWill Healy

    Better Quantum Computing Stock: IonQ vs. D-Wave

    The article compares two quantum computing stocks, IonQ and D-Wave Quantum. IonQ demonstrates industry-leading precision with 99.99% 2-qubit gate fidelities and has a partnership with Nvidia, but faces massive operating losses and an extremely high P/S ratio of 65. D-Wave has achieved real-world applications through its quantum annealing technology and Leap cloud service, but revenue declined 67% year-over-year with a P/S ratio of 475. The author recommends IonQ as the relatively safer choice despite both stocks carrying significant risks and being overvalued.

  3. Globenewswire IncClassiq

    Classiq Introduces Fault Tolerance Engine to Bridge Quantum Applications and Fault-Tolerant Hardware

    Classiq launched its Fault Tolerance Engine, a new capability that translates optimized logical quantum programs into fault-tolerant execution plans and measures physical resources and reliability needed for execution on fault-tolerant quantum computers. The engine addresses the fundamental software challenge of fault-tolerant quantum computing by handling qubit layout, routing, scheduling, and error correction cycles, enabling developers to assess physical feasibility before implementation.

  4. The Motley FoolRick Orford

    IonQ Stock Looks Expensive. Can Scale Justify the Valuation?

    IonQ has demonstrated customer demand for quantum technology, but the key question is whether the company can convert this demand into repeat business, improve manufacturing efficiency, and achieve better cash economics. The company's valuation appears expensive, and upcoming quarters will be critical in showing whether scale is making each dollar of growth more valuable. A partnership with SkyWater may help, but investors need to see concrete evidence of improving unit economics.